GENMAB A/S Quarterly Liabilities in DKK from Q4 2018 to Q4 2024

Taxonomy & unit
ifrs-full: DKK
Summary
Genmab A/S quarterly Liabilities history and growth rate from Q4 2018 to Q4 2024.
  • Genmab A/S Liabilities for the quarter ending December 31, 2024 was 9.11B DKK, a 148% increase year-over-year.
Liabilities, Quarterly (DKK)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 9.11B +5.44B +148% Dec 31, 2024 6-K 2025-02-12
Q2 2024 7.65B +4.43B +137% Jun 30, 2024 6-K 2024-08-08
Q4 2023 3.68B +842M +29.7% Dec 31, 2023 6-K 2025-02-12
Q2 2023 3.22B +229M +7.65% Jun 30, 2023 6-K 2023-08-03
Q4 2022 2.84B +406M +16.7% Dec 31, 2022 6-K 2024-02-14
Q2 2022 2.99B +763M +34.2% Jun 30, 2022 6-K 2022-08-10
Q4 2021 2.43B +409M +20.2% Dec 31, 2021 6-K 2024-02-14
Q2 2021 2.23B -581M -20.7% Jun 30, 2021 6-K 2021-08-11
Q4 2020 2.02B +926M +84.5% Dec 31, 2020 6-K 2022-02-16
Q2 2020 2.81B +2.12B +307% Jun 30, 2020 6-K 2020-08-12
Q4 2019 1.1B +649M +145% Dec 31, 2019 6-K 2021-02-23
Q2 2019 691M Jun 30, 2019 6-K 2019-08-14
Q4 2018 447M Dec 31, 2018 20-F 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.